Concepedia

Sandra Lange

SL

Statistics

Publications

27

Citations

643

H-Index

17

Active since

1998

Affiliations

University of Rostock(Current)

Universidad de Salamanca

Centro de Investigación Biomédica en Red de Cáncer

Charles University

Leiden University Medical Center

Sandra Lange is an author at University of Rostock specializing in oncology, medicine, and life sciences.

ORCID

Publications per year

1998–2023

27

Publications

27

The dual kinase inhibitor NVP-BEZ235 in combination with cytotoxic drugs exerts anti-proliferative activity towards acute lymphoblastic leukemia cells.

Catrin Schult, Meike Dahlhaus, Äenne Glass et al. · PubMed · 2012 · 53 citations

, , +16

Micronucleus formation in human amnion cells after exposure to 50 Hz MF applied horizontally and vertically

Myrtill Simkó, Ralf Kriehuber, Sandra Lange · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · 1998 · 51 citations

, , +10

The multikinase inhibitor Sorafenib displays significant antiproliferative effects and induces apoptosis via caspase 3, 7 and PARP in B- and T-lymphoblastic cells

Catrin Schult, Meike Dahlhaus, Sabine Ruck et al. · BMC Cancer · 2010 · 50 citations · Full text

, , +16

Expression of S1P metabolizing enzymes and receptors correlate with survival time and regulate cell migration in glioblastoma multiforme

Sandra Bien-Möller, Sandra Lange, Tobias Holm et al. · Oncotarget · 2016 · 41 citations · Full text

, , +17

Phenotypic and Functional Characterization of Freshly Isolated and Expanded Canine Regulatory T Cells

Anne Knueppel, Sandra Lange, Anett Sekora et al. · EXPERIMENTAL ANIMALS · 2011 · 33 citations · Full text

, , +14

1–5 of 27